Comprehensive Medical Weight Loss
In clinical trials, tirzepatide, marketed as Zepbound for weight loss and as Mounjaro for diabetes, helped people lose an average of 20% of their body weight, or over 50 pounds!
Wegovy: $499 / Month || Zepbound: $499 / Month As both Wegovy (semaglutide) and Zepbound (tirzepatide) are coming out of shortage, both manufacturers announced new options for cash-pay patients to expand access to these new weight loss treatments. If you…
While tirzepatide (Zepbound / Mounjaro) and semaglutide (Wegovy / Ozempic) are incredibly powerful GLP-1 weight loss medications, recent news reports have highlighted that many people who start treatment discontinue. In this article, I will review 5 tips to improve your…
FDA Approves Zepbound: A New Hope for Sleep Apnea Relief
On Thursday, 12/19/2024, the FDA declared that tirzepatide (Zepbound / Mounjaro) is no longer in shortage. This will have significant impact for patients currently being treated with compounded tirzepatide. Read on to learn more about this decision, and about your…
Tips to Gracefully Bid Farewell to GLP-1 Meds!
It has been an exciting summer for our new GLP-1 weight loss medications, Wegovy (semaglutide) and Zepbound (tirzepatide). This information is current as of 9 Semaglutide At this time, all doses of Wegovy are available at retail pharmacies. Further, all…
